European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Registration Number
- NCT00722267
- Lead Sponsor
- AstraZeneca
- Brief Summary
This study is investigating how patients with severe stable state COPD perceive the variability of their symptoms throughout the day, the week and the year; the impact of these variations on their daily activities or sleep quality and how they deal with their treatments. For this purpose patients will be asked to answer a questionnaire over the phone
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 7400
Inclusion Criteria
- Outpatients with a diagnosis of COPD
- FEV1<50% and FEV1/FVC<0.7 according to lung function data in medical records.
- Smoker or ex-smoker > 10 pack-years
- Informed consent obtained
Read More
Exclusion Criteria
- Ongoing exacerbation of COPD or within the previous 3 months
- Any other significant respiratory disease (including asthma and allergic rhinitis)
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient's perception of the variability of symptoms due to severe stable state COPD throughout the day, the week and the year Once
- Secondary Outcome Measures
Name Time Method Factors that may influence the patient's perception of symptom variability Once Describe how patient use their COPD treatment Once Impact of symptoms (and variability of symptoms) on the patient's morning & daily living activities and sleep quality. Once
Trial Locations
- Locations (1)
Research Site
🇬🇧Westbury, United Kingdom